Lirilumab ELISA Kit
Produktgrößen
96 tests
£1111,00
KDE43401-96TESTS
Über dieses Produkt
- SKU:
- KDE43401
- Zusätzliche Namen:
- BMS-986015, IPH2102, CAS: 1000676-41-4
- Anwendung:
- ELISA
- Weitere Details:
- Lirilumab (IPH2102/BMS-986015/BMS-986015-01) is a fully human monoclonal antibody (mAb) that is designed to block the interaction between KIR2DL-1,-2,-3 inhibitory receptors and their ligands. This drug was developed by Innate Pharma and is licensed to Bristol-Myers Squibb. A phase 2 clinical trial for acute myeloid leukemia (AML) was terminated early ("failed") in 2017. It was registered for a trial for squamous cell carcinoma of the head and neck (SCCHN), but it may be abandoned. On 22 May 2018, a clinical trial for Bladder Cancer was started by PrECOG LLC.
- Format:
- Colorimetric
- Immunogen:
- Lirilumab
- Physischer Zustand:
- Plasma, Serum
- Reichweite:
- 0.31-5 ug/mL
- Empfindlichkeit:
- 0.156 ug/ml
- Versandbedingungen:
- Blue Ice
- Hersteller:
- AntibodySystem
- Typ:
- Assay Kits: ELISAs